Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Clene Inc. (TOTA_old)

NASDAQ
Currency in USD
Disclaimer
10.82
0.00(0.00%)
Closed
TOTA_old Scorecard
Trading near 52-week High
Fair Value
Unlock Value
Day's Range
10.7011.95
52 wk Range
10.7011.95
Prev. Close
12.36
Open
11.88
Day's Range
10.7-11.95
52 wk Range
10.7-11.95
Volume
0
Average Vol. (3m)
-
1-Year Change
0%
Shares Outstanding
3,456,423
Fair Value
Unlock
Dividends Payment Streak
Unlock
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Daily
Weekly
Monthly
More
How do you feel today about TOTA_old?
Vote to see community's results!
or

Clene Inc. Company Profile

Clene Inc, formerly Chelsea Worldwide Inc., is a clinical-stage biopharmaceutical company. The Company through its subsidiary, Clene Nanomedicine, Inc., is focused on the development of therapeutics for neurodegenerative diseases. The Company has innovated a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. It has also advanced into the clinic an aqueous solution of ionic zinc and silver for anti-viral and anti-microbial uses. The Company’s pipeline includes CNM-Au8, CNM-ZnAg, CNM-AgZn-17 and CNM-AuPt7. Its CNM-Au8 is a bioenergetic nanocatalyst, which enhances critical intracellular bioenergetic reactions necessary for repairing and reversing neuronal damage. CNM-AgZn17 is a topical gel polymer suspension of silver and zinc ions. Its CNM-PtAu7 is gold-platinum clean surfaced nanotechnology (CSN) therapeutic, which aims to address the unmet medical needs in several disease areas.

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.